You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of freedom to operate?

Magnesium chloride; sodium bicarbonate; sodium chloride is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
US Patents:0
Tradenames:2
Applicants:1
NDAs:1
Clinical Trials: 295
DailyMed Link:MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE at DailyMed
Recent Clinical Trials for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nextrast, Inc.PHASE1
Shanghai East Hospital of Tongji UniversityNA
Shiyou WeiNA

See all MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE clinical trials

US Patents and Regulatory Information for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Market Dynamics and Financial Trajectory for Magnesium Chloride, Sodium Bicarbonate, and Sodium Chloride

Last updated: August 3, 2025

Introduction

The pharmaceutical sector’s landscape for mineral-based compounds such as magnesium chloride, sodium bicarbonate, and sodium chloride is shaped by diverse market forces and evolving industry dynamics. These compounds serve critical roles across medicinal, industrial, and consumer healthcare sectors, influencing their demand, pricing, and investment trajectories. Understanding market drivers, regulatory frameworks, and future growth prospects for these compounds provides valuable insights for stakeholders and investors.


Market Overview

Magnesium Chloride

Magnesium chloride (MgCl₂) is primarily utilized in medical treatments, including magnesium supplementation, muscle relaxants, and as an anti-inflammatory agent. Its non-pharmaceutical applications include de-icing, dust control, and agriculture. The pharmaceutical demand for MgCl₂ is largely driven by health awareness and the increasing prevalence of magnesium deficiency-related ailments.

Sodium Bicarbonate

Sodium bicarbonate (NaHCO₃), also known as baking soda, has widespread uses in pharmaceuticals, diagnostics, and as an antacid. It is employed in intravenous formulations, kidney treatments, and emergency medicine. The compound’s affordability and multifunctionality underpin its consistent demand within healthcare systems.

Sodium Chloride

Sodium chloride (NaCl), or common salt, remains fundamental in intravenous therapies, dialysis solutions, and respiratory treatments. Its industrial applications—such as in chemical manufacturing and water treatment—also influence its market size. The pharmaceutical segment focuses on sterile, pharmaceutical-grade NaCl for critical care.


Market Dynamics

Demand Drivers

  • Healthcare Industry Growth: An aging population and rising chronic conditions, such as electrolyte imbalances, boost demand for magnesium and sodium-based therapeutics.
  • Regulatory Approvals and Guidelines: Stringent standards for pharmaceutical-grade compounds (e.g., USP, EP) ensure quality but also pose barriers to entry, influencing supply dynamics.
  • Global Health Initiatives: Increased access to healthcare and global disease burden elevate demand, especially in emerging markets.
  • Industrial and Non-Medical Uses: Growth in industrial applications (de-icing, water treatment, agriculture) provide supplemental revenue streams.

Supply Chain Factors

  • Raw Material Availability: Magnesium chloride is sourced from natural brines and seawater, with geopolitical factors affecting supplies. Sodium compounds are predominantly derived from salt deposits, ensuring relatively stable supply, though environmental regulations shape extraction practices.
  • Processing Technologies: Advances in extraction and purification enhance product quality and reduce costs, impacting profitability.
  • Environmental Regulations: Stricter environmental policies regarding resource extraction and waste management can restrict supply and increase costs.

Pricing Trends

Prices are influenced by raw material costs, manufacturing efficiencies, and regulatory compliance costs. Recently, the volatility in energy prices and environmental compliance expenditures has affected production costs, especially for magnesium chloride.

Competitive Landscape

Major players include chemical conglomerates and specialized pharmaceutical ingredient producers. Vertical integration and strategic acquisitions are common to secure supply chains and expand market share.

Regulatory Environment

Regulatory standards, especially concerning pharmaceutical-grade quality and safety, significantly influence market entry and operations. Post-pandemic, increased scrutiny and demand for high-purity products have elevated compliance costs but also opened opportunities for high-quality suppliers.


Financial Trajectory

Revenue and Market Growth

Analyses forecast a steady compound annual growth rate (CAGR) of approximately 4-6% over the next five years for magnesium chloride and sodium bicarbonate markets, driven by global healthcare expansion. Sodium chloride, owing to its dual medical-industrial demand, exhibits even more resilient growth, with a projected CAGR of 3-5%.

Profit Margins

Profitability hinges on raw material costs, regulatory compliance, and market competition. Pharmaceutical-grade compounds command higher margins relative to industrial grades. Recent cost pressures from environmental regulations are squeezing margins but prompt investment in cleaner technologies.

Investment Trends

Investors are increasingly focused on companies investing in sustainable extraction methods and expanding capacity in emerging markets. Capital flows are also directed toward R&D for novel formulations and delivery systems leveraging these compounds.

Emerging Opportunities

  • Personalized Medicine: Synthetic modifications and specialty formulations open avenues for higher-margin products.
  • Bioavailability Enhancements: Innovations in delivery mechanisms can expand medical applications.
  • Supply Chain Optimization: Digitalization and regional manufacturing hubs reduce costs and improve responsiveness.

Future Outlook

The pharmaceutical and industrial markets for magnesium chloride, sodium bicarbonate, and sodium chloride are poised for moderate growth, driven by demographic trends, technological advancements, and healthcare infrastructure expansion.

  • Magnesium chloride, with its expanding medical applications, will benefit from increased research and formulation innovation.
  • Sodium bicarbonate remains a staple due to its cost-effectiveness and versatility, with growth driven by demand in diagnostic and emergency medicine.
  • Sodium chloride will maintain its essential role in medical treatments and industrial applications, with potential for growth in biopharmaceutical formulations and specialty applications.

Environmental sustainability practices and regulatory compliance will continue to shape manufacturing costs and supply chain strategies, influencing the financial trajectory.


Key Takeaways

  • Demand Stability and Growth: All three compounds demonstrate stable demand, with magnesium chloride and sodium bicarbonate poised for higher growth segments within healthcare.
  • Regulatory Impact: Stringent quality standards raise barriers to entry but also increase product value for compliant manufacturers.
  • Innovation and Sustainability: Investment in sustainable sourcing and advanced formulation techniques offers competitive advantages.
  • Market Risks: Supply disruptions from geopolitical or environmental policies could influence pricing and availability.
  • Strategic Positioning: Companies focusing on high-quality, certified products and expanding into emerging markets are better positioned for long-term growth.

FAQs

1. How does environmental regulation affect the production and pricing of magnesium chloride?
Environmental regulations increase compliance costs associated with resource extraction and waste management, potentially leading to higher production costs and elevated product pricing.

2. What are the key growth drivers for sodium bicarbonate in the pharmaceutical industry?
Its widespread use as an antacid, in dialysis, and diagnostic procedures sustains its demand, compounded by the continuous need for cost-effective, versatile therapeutic agents.

3. Are there emerging markets that could significantly impact the sodium chloride market?
Yes, expanding healthcare infrastructure in Asia-Pacific and Africa, coupled with growth in biopharmaceutical applications, offers substantial opportunities for sodium chloride demand.

4. How might technological advances influence the profitability of magnesium chloride manufacturing?
Innovations in extraction and purification can lower costs, improve quality, and enable the development of specialized formulations, thereby enhancing profitability.

5. What role do regulatory standards play in shaping investments in these mineral compounds?
Strict adherence to pharmacopoeia standards (USP, EP) necessitates investments in quality assurance, impacting costs but also creating barriers that favor established, compliant suppliers.


Sources:

[1] MarketsandMarkets, "Mineral Pharmaceuticals Market," 2022.
[2] Grand View Research, "Pharmaceutical Salts & Mineral Supplements," 2023.
[3] Transparency Market Research, "Global Sodium Chloride Market," 2023.
[4] Pharmaceutical Data & Analysis, "Regulatory Trends in Mineral Pharmaceuticals," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.